10.41USD-1.37%Mkt Cap: 1.35B USDP/E: —Last update: 2026-06-01
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clin…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap1.35B USD
Enterprise Value1.63B USD
Revenue (TTM)745.97M USD
Gross Profit314.29M USD
Net Income (TTM)-108.03M USD
Revenue/Share5.803 USD
Last Price10.41 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)28.86
PEG2.09
EV/EBITDA382.52
EV/Revenue2.19
P/S1.84
P/B1.62
EPS (TTM)-0.77
EPS (Forward)0.36
52W Range
4.72063% of range13.74
52W High13.74 USD
52W Low4.720 USD
Profitability
Gross Margin43.21%
Oper. Margin-9.34%
EBITDA Margin0.57%
Profit Margin-14.85%
ROE-12.91%
ROA-7.94%
Growth
Revenue Growth11.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF5.23M USD
CapEx (TTM)27.01M USD
FCF Margin4.45%
FCF Yield2.45%
Net Debt262.39M USD
Net Debt/EBITDA61.49
Balance Sheet
Debt/Equity0.49
Current Ratio4.42
Quick Ratio3.71
Book Value/Sh6.486 USD
Cash/Share1.122 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)15.06 USD
Target Range11.00 USD – 25.00 USD
# Analysts9
Ownership
Shares Out.130.21M
Float118.40M
Insiders1.93%
Institutions108.40%
Short Interest
Short Ratio3.4d
Short % Float7.80%
Short % Out.6.62%
Shares Short8.62M
Short (prev mo.)7.88M
Technical
SMA 508.412 (+23.7%)
SMA 2009.687 (+7.5%)
Beta1.80
S&P 52W Chg27.94%
Avg Vol (30d)1.86M
Avg Vol (10d)1.16M
Technical Indicators
RSI (14)74.2
MACD0.3590
MACD Signal0.1736
MACD Hist.+0.1854
BB Upper10.23 USD
BB Middle9.008 USD
BB Lower7.782 USD
BB Width27.22%
ATR (14)0.4938 USD
Vol Ratio (20d)0.54x